Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders and get inspired to improve patient care.

Implementing AGA’s Newest IBD Guideline in Your Practice

Sept. 18, 2017

Experts will provide guidance around the latest IBD guidelines at the 2018 Crohn’s & Colitis Congress.™

IBD No Obstacle to Safe Pregnancy

Sept. 14, 2017

If IBD is in remission at conception and during gestation.

Blog: Could the Microbiota Link Metabolic Syndrome with Inflammation?

Sept. 14, 2017

Researchers report that an altered microbiota may cause inflammation by attaining greater proximity to epithelial cells. Read more on the AGA Journals blog.

RFP Issued to Identify Best Practices in IBD Shared-Decision Making

Sept. 13, 2017

Applications accepted from Sept. 11 through Oct. 13

Congressional Committees Approve Increase for NIH Funding

Sept. 13, 2017

Senate bill includes funding for gastrointestinal disorders and cancers.

Share Your Cutting-Edge IBD Research

Sept. 11, 2017

The processing fee for oral and/or poster presentation is being waived. Submissions are due by October 31 at 9 p.m. ET.

Leading Patient Organizations Collaborate to Improve Patient Care in IBD Through Shared Decision-Making

Sept. 11, 2017

Blog: Do Fatty Acids Increase Risk of Ulcerative Colitis Flares?

Sept. 6, 2017

Palm oil, coconut oil and dairy fats may increase flares according to prospective study of 412 patients. Read more on the AGA Journals blog.

American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Sept. 1, 2017

This document presents the official recommendations of the AGA on therapeutic drug monitoring in inflammatory bowel disease.

American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases

Sept. 1, 2017

This review focuses on the application of TDM for biologic therapy, specifically anti-tumor necrosis factor a agents, and for thiopurines.

Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis

Sept. 1, 2017

We associated combined treatment with immunomodulators with reduced risk of formation of antibodies against TNF antagonists in patients with IBD.

SVR Good Indicator of Hep C Treatment Benefit

Aug. 31, 2017

Experts blast Cochrane review suggesting inadequate evidence for effectiveness of direct-acting antivirals

IBD: Biologics, Preservative Surgery Reduce Need for Permanent Stomas

Aug. 31, 2017

Still, despite better control of progression, surgery rates for Crohn's disease remain stubbornly high

Final Call for Research Scholar Award Applications

Aug. 31, 2017

Submit your documents by Sept. 8 to be considered for these grants from the AGA Research Foundation.

AGA Releases New Evidence-Based Clinical Guideline on Therapeutic Drug Monitoring in IBD

Aug. 30, 2017

Reactive therapeutic drug monitoring can guide treatment in IBD patients.

Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice

Aug. 24, 2017

We identified 64 SNPs whose association with risk for IBD is modified by tobacco smoking.

IBD 115: Therapeutic Drug Monitoring in IBD

Aug. 24, 2017

Learn more about Therapeutic Drug Monitoring, based on the AGA Clinical Guideline "Therapeutic Monitoring in Inflammatory Bowel Disease."

A Message for IBD Professionals

Aug. 23, 2017

In this brief video, Dr. Brent Polk shares why the Crohn’s & Colitis Congress™ is the must-attend meeting for IBD education.

Pfizer Accepting Applications for Visiting Professorship Program

Aug. 23, 2017

Up to $10,000 in funding available to organizations hosting IBD medical experts.

Does Asthma Increase Risk for Inflammatory Bowel Diseases?

Aug. 22, 2017

Researchers have associated asthma with later development of Crohn’s disease and with ulcerative colitis. Read more on the AGA Journals blog.

IBD in the ED

Aug. 17, 2017

Emergency visits are a costly component of inflammatory bowel disease (IBD) care. Factors that can ward off flares are discussed in the AGA-MedPage Today Reading Room.

Quality Management of IBD Patients Through Specialty Medical Homes (SMHs)

Aug. 17, 2017

SMHs can reduce costs of care while improving the patient-centered experience and outcomes.

Submit Your IBD-Related Abstract for the Crohn’s & Colitis Congress

Aug. 16, 2017

Abstracts will be accepted from Aug. 15 through Oct. 31.